Newton-based Alcresta Inc. pulled in more $10 million for a product that will help people such as cancer patients, premature infants and those with cystic fibrosis who cannot absorb the all the calories from food and drinks.
This second round of funding has brought the company’s investments to a $20 million, according to a story in the Boston Globe. The investors include Third Rock Ventures of Boston and Bessemer Venture Partners, a New York firm with an office in Cambridge.
Co-founders Alexey Margolin and Robert Gallotto are also working on a drug to treat kidney stones and renal disease. That venture is called Allena Pharmaceuticals, also based in Newton.
Interested in local real estate?Subscribe to Patch's new newsletter to be the first to know about open houses, new listings and more.
Read the entire Boston Globe story by clicking here
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
We’ve removed the ability to reply as we work to make improvements. Learn more here
